Abstract
(1) Background: Decellularized xenogeneic tissues are promising matrices for developing tissue-engineered cardiovascular grafts. In vitro recellularization of these tissues with stromal cells can provide a better in vivo remodelling and a lower thrombogenicity of the graft. The process of recellularization can be accelerated using a cultivation bioreactor simulating physiological conditions and stimuli. (2) Methods: Porcine pericardium was decellularized using a custom-built decellularization system with an optimized protocol. Autologous porcine adipose-derived stromal cells (PrASCs), isolated from the subcutaneous fat tissue, were used for recellularizing the decellularized pericardium. A custom cultivation bioreactor allowing the fixing of the decellularized tissue into a special cultivation chamber was created. The bioreactor maintained micro-perfusion and pulsatile pressure stimulation in order to promote the ingrowth of PrASCs inside the tissue and their differentiation. (3) Results: The dynamic cultivation promoted the ingrowth of cells into the decellularized tissue. Under static conditions, the cells penetrated only to the depth of 50 µm, whereas under dynamic conditions, the tissue was colonized up to 250 µm. The dynamic cultivation also supported the cell differentiation towards smooth muscle cells (SMCs). In order to ensure homogeneous cell colonization of the decellularized matrices, the bioreactor was designed to allow seeding of the cells from both sides of the tissue prior to the stimulation. In this case, the decellularized tissue was recolonized with cells within 5 days of dynamic cultivation. (4) Conclusions: Our newly designed dynamic bioreactor markedly accelerated the colonization of decellularized pericardium with ASCs and cell differentiation towards the SMC phenotype.
Highlights
Cardiovascular diseases belong to the most frequent causes of death or life quality impairment.Currently, autologous vessel replacements such as the saphenous vein represent the gold standard grafts for small-diameter vessels, and in many factors, they outperform synthetic alternatives
We demonstrate a novel cultivation system allowing the recellularization of planar decellularized tissues intended as cardiovascular patches
We have prepared decellularized pericardium repopulated with adipose tissue-derived stromal cells for potential use as implantable cardiovascular patches
Summary
Cardiovascular diseases belong to the most frequent causes of death or life quality impairment.Currently, autologous vessel replacements such as the saphenous vein represent the gold standard grafts for small-diameter vessels (below 6 mm), and in many factors, they outperform synthetic alternatives. Autologous grafts, are of limited availability, and an invasive approach for their harvesting is required. In many cases, they are unsuitable for use due to unfavorable anatomy (gracility, branching, thrombosis) or previous harvest [1]. Allograft vessels from cadaveric donors provide an alternative source for bypass grafting. These grafts can be cold-stored or cryopreserved in tissue banks; they are not immediately available for emergent surgery, and their long-term patency is limited [2]. Synthetic grafts act in many cases as suitable replacements; they show a reduced clinical efficacy, especially in small-calibre applications [3]. There is a great clinical demand for new biomaterials providing feasible solutions, including proper mechanical support, functional tissue regeneration, and a non-thrombogenic surface [4]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.